SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025637
Filing Date
2020-05-15
Accepted
2020-05-15 07:11:25
Documents
57
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q stok-10q_20200331.htm 10-Q 1528771
2 EX-31.1 stok-ex311_6.htm EX-31.1 15909
3 EX-31.2 stok-ex312_9.htm EX-31.2 15955
4 EX-32.1 stok-ex321_7.htm EX-32.1 7205
5 EX-32.2 stok-ex322_8.htm EX-32.2 7881
  Complete submission text file 0001564590-20-025637.txt   4130561

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stok-20200331.xml EX-101.INS 635962
7 XBRL TAXONOMY EXTENSION SCHEMA stok-20200331.xsd EX-101.SCH 39403
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stok-20200331_cal.xml EX-101.CAL 37561
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stok-20200331_def.xml EX-101.DEF 70637
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20200331_lab.xml EX-101.LAB 260277
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20200331_pre.xml EX-101.PRE 190972
Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 20880566
SIC: 2834 Pharmaceutical Preparations